Policy & Sector Insights

AJMC
With the increasing prevalence of oral oncolytics, PBMs and community oncologists have seen a concurrent increase in their mutual interaction. Each can rail against the other, claiming better, faster, and more cost-effective care, or community oncologists can find a way to co-exist with and manage PBMs in a manner that would benefit patients and their practice….Read More.

Fierce Healthcare
Like a car dealership, it’s hard to know a PBM’s actual costs or how that impacts what patients pay…Read More.

Inside Health Policy
Representatives from the American Medical Association and the American Hospital Association called for increased drug pricing transparency and reduced regulations to increase competition at a panel on Monday (Sept. 25) on the cost of drugs at America’s Health Insurance Plans’ Medicare conference…Read More.

ABC News
Watch Here.

The American Prospect
“Pharmacy benefit managers”—companies that claim to lower prices—actually jack them up…Read More.

Fierce Healthcare
For Americans younger than 50, the leading cause of death used to be injuries caused by accidents. Now, the biggest killer isn’t car crashes or ladder falls—it’s drug overdoses…Read More.

Kaiser Health News
Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline…Read More.

Forbes
Prescription drug costs are a hot political issue, not as much because of the share of the U.S. health care dollar they consume but because consumers pay a larger share of their drug costs out of pocket than they do for other health care…Read More.

Bloomberg Gov
A new law in Connecticut would close a drug price loophole that’s been the subject of more than a dozen lawsuits around the U.S., taking aim at a practice by pharmacy benefit managers called pharmacy clawbacks…Read More.